Overview

Study With Improved Solubility Pazopanib

Status:
Completed
Trial end date:
2017-08-28
Target enrollment:
Participant gender:
Summary
The pharmacokinetics of a new formulation with Pazopanib will be studied. This will be done in a patient cohort of n = 12.
Phase:
Early Phase 1
Details
Lead Sponsor:
The Netherlands Cancer Institute